Amides (sang) < Amides (usage thérapeutique) < Aminoquinoléines (effets indésirables)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Amides (usage thérapeutique)

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]

Ident.	Authors (with country if any)	Title
000020 (2021)	Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie]	[The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000158 (2021)	Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]	Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000290 (2021)	Nursel Çal K Ba Aran [Turquie] ; O Uz Abdullah Uyaro Lu [Turquie] ; Gülçin Telli Dizman [Turquie] ; Lale Öz K [Turquie] ; Taha Koray Ahin [Turquie] ; Zahit Ta [Turquie] ; Ahmet Ça Kan Nkaya [Turquie] ; Sevilay Karahan [Turquie] ; Ehnaz Alp [Turquie] ; Alpaslan Alp [Turquie] ; Gökhan Metan [Turquie] ; P Nar Zarakol [Turquie] ; Gülay Sain Güven [Turquie] ; Erife Gül Öz [Turquie] ; Arzu Topeli [Turquie] ; Ömrüm Uzun [Turquie] ; Murat Akova [Turquie] ; Serhat Ünal [Turquie]	Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
000294 (2021)	Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]	One year update on the COVID-19 pandemic: Where are we now?
000338 (2021)	Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni]	Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000504 (2021)	Nurullah Okumu [Turquie] ; Ne E Demirtürk [Turquie] ; R Za Aytaç Çetinkaya [Turquie] ; Rahmet Güner [Turquie] ; Smail Ya Ar Avc [Turquie] ; Semiha Orhan [Turquie] ; Petek Konya [Turquie] ; Bengü Aylan [Turquie] ; Ay Egül Karalezli [Turquie] ; Levent Yamanel [Turquie] ; Bircan Kayaaslan [Turquie] ; Gülden Y Lmaz [Turquie] ; Ümit Sava Ç [Turquie] ; Fatma Eser [Turquie] ; Gürhan Ta K N [Turquie]	Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
000511 (2021)	Rujipas Sirijatuphat [Thaïlande] ; Yupin Suputtamongkol [Thaïlande] ; Nasikarn Angkasekwinai [Thaïlande] ; Navin Horthongkham [Thaïlande] ; Methee Chayakulkeeree [Thaïlande] ; Pinyo Rattanaumpawan [Thaïlande] ; Pornpan Koomanachai [Thaïlande] ; Susan Assanasen [Thaïlande] ; Yong Rongrungruang [Thaïlande] ; Nitipatana Chierakul [Thaïlande] ; Ranistha Ratanarat [Thaïlande] ; Anupop Jitmuang [Thaïlande] ; Walaiporn Wangchinda [Thaïlande] ; Wannee Kantakamalakul [Thaïlande]	Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital.
000514 (2021)	Maria Gavriatopoulou [Grèce] ; Ioannis Ntanasis-Stathopoulos [Grèce] ; Eleni Korompoki [Grèce, Royaume-Uni] ; Despina Fotiou [Grèce] ; Magdalini Migkou [Grèce] ; Ioannis-Georgios Tzanninis [Royaume-Uni] ; Theodora Psaltopoulou [Grèce] ; Efstathios Kastritis [Grèce] ; Evangelos Terpos [Grèce] ; Meletios A. Dimopoulos [Grèce]	Emerging treatment strategies for COVID-19 infection.
000594 (2021)	Rahmet Guner [Turquie] ; Imran Hasanoglu [Turquie] ; Bircan Kayaaslan [Turquie] ; Adalet Aypak [Turquie] ; Esragul Akinci [Turquie] ; Hurrem Bodur [Turquie] ; Fatma Eser [Turquie] ; Ayse Kaya Kalem [Turquie] ; Orhan Kucuksahin [Turquie] ; Ihsan Ates [Turquie] ; Aliye Bastug [Turquie] ; Yasemin Tezer Tekce [Turquie] ; Zeynep Bilgic [Turquie] ; Fahriye Melis Gursoy [Turquie] ; Hatice Nisa Akca [Turquie] ; Seval Izdes [Turquie] ; Deniz Erdem [Turquie] ; Emra Asfuroglu [Turquie] ; Habibe Hezer [Turquie] ; Hatice Kilic [Turquie] ; Musa C Vak [Turquie] ; Sibel Aydogan [Turquie] ; Turan Buzgan [Turquie]	Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
000729 (2021)	Ambedkar Kumar Yadav [République populaire de Chine] ; Siwan Wen [République populaire de Chine] ; Xianghuai Xu [République populaire de Chine] ; Li Yu [République populaire de Chine]	Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
000777 (2021)	Theerachai Thammathiwat [Thaïlande] ; Somkanya Tungsanga [Thaïlande] ; Kanitha Tiankanon [Thaïlande] ; Pattama Torvorapanit [Thaïlande] ; Worawat Chumpangern [Thaïlande] ; Suwasin Udomkarnjananun [Thaïlande] ; Yingyos Avihingsanon [Thaïlande] ; Thitiwat Sriprasart [Thaïlande] ; Nattachai Srisawat [Thaïlande] ; Kamonwan Jutivorakool [Thaïlande] ; Leilani Paitoonpong [Thaïlande] ; Opass Putcharoen [Thaïlande] ; Natavudh Townamchai [Thaïlande]	A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient.
000807 (2020)	Melanie Bilbul [États-Unis] ; Patricia Paparone [États-Unis] ; Anna M. Kim [États-Unis] ; Shruti Mutalik [États-Unis] ; Carrie L. Ernst [États-Unis]	Psychopharmacology of COVID-19.
000832 (2020)	Murat Çap [Turquie] ; Önder Bilge [Turquie] ; Ferhat I K [Turquie] ; Cengiz Burak [Turquie] ; Ali Karagöz [Turquie] ; Ümit Nci [Turquie] ; Abdurrahman Akyüz [Turquie] ; Burhan Aslan [Turquie] ; Bernas Alt Nta [Turquie] ; Rojhat Alt Nda [Turquie] ; Lyas Kaya [Turquie] ; Mehmet Ahin Ad Yaman [Turquie] ; Muhammed Süleymano Lu [Turquie] ; Afak Kaya [Turquie] ; Erkan Baysal [Turquie]	The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.
000947 (2020)	Lenka Petroušová [République tchèque] ; Simona Da Silva ; Lud K Rožnovsk ; Irena Martinková	[Clinical progression of the first wave of novel coronavirus infection in Ostrava].
000A44 (2020)	Shio-Shin Jean [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan]	Treatment options for COVID-19: The reality and challenges.
000A47 (2020)	Waquar Ahsan [Arabie saoudite] ; Shamama Javed [Arabie saoudite] ; Mohammed Al Bratty [Arabie saoudite] ; Hassan A. Alhazmi [Arabie saoudite] ; Asim Najmi [Arabie saoudite]	Treatment of SARS-CoV-2: How far have we reached?
000A53 (2020)	Hilary Miller-Handley [États-Unis] ; Keith Luckett [États-Unis] ; Amit Govil [États-Unis]	Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
000C29 (2020)	Gayathri Vaidyanathan	Scientists criticize use of unproven COVID drugs in India.
000E35 (2020)	Saba Shamim [Pakistan] ; Maryam Khan [Pakistan] ; Zelal Jaber Kharaba [Émirats arabes unis] ; Munazza Ijaz [Pakistan] ; Ghulam Murtaza [Pakistan]	Potential strategies for combating COVID-19.
000E46 (2020)	N. Trivedi [États-Unis] ; A. Verma ; D. Kumar	Possible treatment and strategies for COVID-19: review and assessment.
000E56 (2020)	Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis] ; Ali Pourmand [États-Unis]	Pharmacotherapy in COVID-19; A narrative review for emergency providers.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Amides (usage thérapeutique)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Amides (usage thérapeutique)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Amides (usage thérapeutique)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021